GGrantIndex
← Leaderboards

Phillip B Hylemon

Virginia Commonwealth University

Google Scholar ↗PubMed ↗ORCID ↗
$8,797,545
Attributed
$12,607,214
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,531,432 · 9
VA$0 · 1

By mechanism

R01$11,680,360 · 5
P01$7,221,490 · 3
R56$629,582 · 1
I01$0 · 1

Top collaborators

Others in their field

Top investigators on “Genes”

Research focus

GenesBile AcidsReportingLiverMouse ModelHepatocyteProteinsMolecularPlayGrowthPathway InteractionsChronicIn VivoCholesterolProto-Oncogene Proteins C-AktInhibitor/AntagonistG-Protein-Coupled ReceptorsSignal PathwaySignal TransductionMediatingLinkPhysiologicalHomeostasisBase

Grant awards (56)

Sphingolipids in alcoholic liver disease$523,062
R01 · FY2025 · AA
Sphingolipids in alcoholic liver disease$523,062
R01 · FY2024 · AA
LncRNA H19 in Cholestatic Liver Diseases$629,582
R56 · FY2023 · DK
Sphingolipids in alcoholic liver disease$523,062
R01 · FY2023 · AA
LncRNA H19 in Cholestatic Liver Diseases$536,469
R01 · FY2021 · DK
LncRNA H19 in Cholestatic Liver Diseases$536,469
R01 · FY2020 · DK
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$399,609
R01 · FY2020 · DK
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds$0
I01 · FY2020 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$536,469
R01 · FY2019 · DK
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$393,548
R01 · FY2019 · DK
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds$0
I01 · FY2019 · VA · contact PI
LncRNA H19 in Cholestatic Liver Diseases$535,606
R01 · FY2018 · DK
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$390,905
R01 · FY2018 · DK
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds$0
I01 · FY2018 · VA · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$390,481
R01 · FY2017 · DK
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds$0
I01 · FY2017 · VA · contact PI
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis$411,742
R01 · FY2016 · DK
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$325,163
R01 · FY2015 · DK · contact PI
Role of Bile Acids and Gut Bacteria in GI Diseases$0
I01 · FY2015 · VA · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$325,163
R01 · FY2014 · DK · contact PI
Role of Bile Acids and Gut Bacteria in GI Diseases$0
I01 · FY2014 · VA · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$313,783
R01 · FY2013 · DK · contact PI
Role of Bile Acids and Gut Bacteria in GI Diseases$0
I01 · FY2013 · VA · contact PI
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism$325,163
R01 · FY2012 · DK · contact PI
Role of Bile Acids and Gut Bacteria in GI Diseases$0
I01 · FY2012 · VA · contact PI
Bile Acid Activated Cell Signaling in the Liver and Nutrition$186,875
R01 · FY2011 · DK · contact PI
Bile Acid Activated Cell Signaling in the Liver and Nutrition$283,325
R01 · FY2010 · DK · contact PI
Bile Acid Activated Cell Signaling in the Liver and Nutrition$286,359
R01 · FY2009 · DK · contact PI
HIV Protease Inhibitors and Hepatic Lipid Dysregulation$308,676
R01 · FY2008 · AI · contact PI
Bile Acid Activated Cell Signaling in the Liver and Nutrition$286,525
R01 · FY2008 · DK · contact PI
HIV Protease Inhibitors and Hepatic Lipid Dysregulation$314,815
R01 · FY2007 · AI · contact PI
Bile Acid Activated Cell Signaling in the Liver and Nutrition$292,534
R01 · FY2007 · DK · contact PI
LIVER/INTESTINAL METABOLISM OF BILE ACIDS/CHOLESTEROL$991,925
P01 · FY2006 · DK · contact PI
HIV Protease Inhibitors and Hepatic Lipid Dysregulation$324,379
R01 · FY2006 · AI · contact PI
Bile Acid Activated Cell Signaling in the Liver and Nutrition$301,432
R01 · FY2006 · DK · contact PI
LIVER/INTESTINAL METABOLISM OF BILE ACIDS/CHOLESTEROL$986,213
P01 · FY2005 · DK
HIV Protease Inhibitors and Hepatic Lipid Dysregulation$332,345
R01 · FY2005 · AI
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$261,000
R01 · FY2005 · DK
LIVER/INTESTINAL METABOLISM OF BILE ACIDS/CHOLESTEROL$957,482
P01 · FY2004 · DK
HIV Protease Inhibitors and Hepatic Lipid Dysregulation$332,500
R01 · FY2004 · AI
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$261,000
R01 · FY2004 · DK
LIVER/INTESTINAL METABOLISM OF BILE ACIDS/CHOLESTEROL$929,594
P01 · FY2003 · DK
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$261,000
R01 · FY2003 · DK
LIVER/INTESTINAL METABOLISM OF BILE ACIDS/CHOLESTEROL$920,557
P01 · FY2002 · DK
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$261,000
R01 · FY2002 · DK
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$69,065
R01 · FY2002 · DK
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$66,774
R01 · FY2002 · DK
CORE--CELL CULTURE AND MOLECULAR BIOLOGY$0
P01 · FY2002 · DK
MOLECULAR BIOLOGY OF INTESTINAL BILE SALT METABOLISM$0
P01 · FY2002 · DK
LIVER/INTESTINAL METABOLISM ON BILE ACIDS/CHOLESTEROL$1,082,535
P01 · FY2001 · DK
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM$261,000
R01 · FY2001 · DK
CORE--CELL CULTURE AND MOLECULAR BIOLOGY LABORATORY$0
P01 · FY2001 · DK
BILE ACID METABOLISM BY INTESTINAL ANAEROBIC BACTERIA$0
P01 · FY2001 · DK
LIVER/INTESTINAL METABOLISM ON BILE ACIDS/CHOLESTEROL$1,055,912
P01 · FY2000 · DK
CORE--CELL CULTURE AND MOLECULAR BIOLOGY LABORATORY$148,636
P01 · FY2000 · DK
BILE ACID METABOLISM BY INTESTINAL ANAEROBIC BACTERIA$148,636
P01 · FY2000 · DK